ConductScience.org, home

Paper40565229

Peptide-Engineered Seliciclib Nanomedicine for Brain-Targeted Delivery and Neuroprotection.

He GZ and 1 other. Int J Mol Sci, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Peptide-Engineered Seliciclib Nanomedicine for Brain-Targeted Delivery and Neuroprotection. Papers, record 40565229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40565229

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Peptide-Engineered Seliciclib Nanomedicine for Brain-Targeted Delivery and Neuroprotection.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-06-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1He GZGuan Zhen
2Lin WJWen Jen

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neuroprotective AgentsMajor topic
BrainMajor topic
PeptidesMajor topic
NeuroprotectionMajor topic
Animals
Humans
Blood-Brain Barrier
Mice
Nanomedicine
Nanoparticles
Tissue Distribution
Cell Line, Tumor
Drug Delivery Systems
Cell Line
Male

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MOST 109-2320-B-002-046-MY3National Science and Technology CouncilPubMed

Source PubMed

Download CSV of grants

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136297647Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy.Pharmaceutics2022https://conductscience.org/library/papers/36297647PubMed
227374198Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.Int J Pharm2016https://conductscience.org/library/papers/27374198PubMed
337242623Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model.Pharmaceutics2023https://conductscience.org/library/papers/37242623PubMed
426826308Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.J Control Release2016https://conductscience.org/library/papers/26826308PubMed
531995153Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells.Invest Ophthalmol Vis Sci2020https://conductscience.org/library/papers/31995153PubMed
620380819Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.Brain Res2010https://conductscience.org/library/papers/20380819PubMed
739608455Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment.J Control Release2025https://conductscience.org/library/papers/39608455PubMed
827208862Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.J Control Release2016https://conductscience.org/library/papers/27208862PubMed
922830613Roscovitine sensitizes leukemia and lymphoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.Leuk Lymphoma2013https://conductscience.org/library/papers/22830613PubMed
1015111235Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists.Neurotox Res2004https://conductscience.org/library/papers/15111235PubMed
1128118852The SH-SY5Y cell line in Parkinson's disease research: a systematic review.Mol Neurodegener2017https://conductscience.org/library/papers/28118852PubMed
1211277922Receptor mediated uptake of peptides that bind the human transferrin receptor.Eur J Biochem2001https://conductscience.org/library/papers/11277922PubMed
1335646531The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers.Acta Pharm Sin B2022https://conductscience.org/library/papers/35646531PubMed
1437376196Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics.Pharmaceutics2023https://conductscience.org/library/papers/37376196PubMed
1528629814Abcb1a (P-glycoprotein) limits brain exposure of the anticancer drug candidate seliciclib in vivo in adult mice.Brain Res Bull2017https://conductscience.org/library/papers/28629814PubMed
1638857748Blood brain barrier-targeted lipid nanoparticles improved the neuroprotection of Ferrostatin-1 against cerebral ischemic damage in an experimental stroke model.Exp Neurol2024https://conductscience.org/library/papers/38857748PubMed
1731189016Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model.Hum Mol Genet2019https://conductscience.org/library/papers/31189016PubMed
1817286588Dopaminergic neurons intrinsic to the striatum.J Neurochem2007https://conductscience.org/library/papers/17286588PubMed
1939336425Nanomedicine in Neuroprotection, Neuroregeneration, and Blood-Brain Barrier Modulation: A Narrative Review.Medicina (Kaunas)2024https://conductscience.org/library/papers/39336425PubMed
2033396266The Role of CDK5 in Tumours and Tumour Microenvironments.Cancers (Basel)2020https://conductscience.org/library/papers/33396266PubMed

See all 56 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CDK51020PubTator's text mininghttps://conductscience.org/library/genes/1020

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40565229

GET https://conductscience.org/api/papers/v1/40565229/references?page=2